GlaxoSmithKline Director of Business Development Salaries in Elizabethtown, KY
The average GlaxoSmithKline Director of Business Development in Elizabethtown, KY earns an estimated $214,085 annually, which includes an estimated base salary of $164,337 with a $49,747 bonus. GlaxoSmithKline's Director of Business Development compensation is $47,783 more than the US average for a Director of Business Development. Director of Business Development salaries at GlaxoSmithKline in Elizabethtown, KY can range from $73,000 - $390,000.
In Elizabethtown, KY, The Business Development Department at GlaxoSmithKline earns $2,516 more on average than the Engineering Department.
Last updated 2 years ago.
- $164,337
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at GlaxoSmithKline
In Elizabethtown, KY, Directors of Business Development earn $2,683 more than Directors of Business Development.
Compensation at GlaxoSmithKline by Department
In Elizabethtown, KY, The Business Development Department averages $2,516 more than the Engineering Department, and $10,023 less than the Product Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to GlaxoSmithKline reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to GlaxoSmithKline reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at GlaxoSmithKline Rate Their Compensation
The majority of Directors of Business Development at GlaxoSmithKline believe they're compensated fairly. 100% of Directors of Business Development at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline
